ABSTRACT
Antibiotic resistance is an urgent public health threat. Actions to reduce this threat include requiring prescriptions for antibiotic use, antibiotic stewardship programs, educational programs targeting patients and healthcare providers, and limiting antibiotic use in agriculture, aquaculture, and animal husbandry. Wastewater surveillance might complement clinical surveillance by tracking time/space variation essential for detecting outbreaks and evaluating efficacy of evidence-based interventions; identifying high-risk populations for targeted monitoring; providing early warning of the emergence and spread of antibiotic resistant bacteria and identifying novel antibiotic resistant threats. Wastewater surveillance was an effective early warning system for SARS-CoV-2 spread and detection of the emergence of new viral strains. In this data-driven commentary we explore whether monitoring wastewater for antibiotic resistant genes and/or bacteria resistant to antibiotics might provide useful information for public health action. Using carbapenem resistance as an example, we highlight technical challenges associated with using wastewater to quantify temporal/spatial trends in antibiotic resistant bacteria (ARBs) and antibiotic resistant genes (ARGs) and compare with clinical information. While ARGs and ARBs are detectable in wastewater enabling early detection of novel ARGs, quantitation of ARBs and ARGs with current methods is too variable to reliably track space/time variation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Michigan Department of Health & Human Services through the Michigan Sequencing Academic Partnership for Public Health Innovation and Response (MI-SAPPHIRE) grant (S MA-2022 (ELCEDE-UM) 10/01/2021 to 07/31/2024, (BF mPI), and the wastewater surveillance program (SEWER network grant, KRW and MCE coPIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The used only openly available human data that were originally located at https://www.michigan.gov/mdhhs/-/media/Project/Websites/mdhhs/HAI-SHARP/CRE/CP-CRE-Surveillance-Report-2018-2022-Final.pdf?rev=b5ee21278e6c4c1c91e7ce116bf25403&hash=5AE501DE9961C2B742D69CD5CA453B16 (Accessed February 28, 2024)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding information: This work was supported by the Michigan Department of Health & Human Services through the Michigan Sequencing Academic Partnership for Public Health Innovation and Response (MI-SAPPHIRE) grant (S MA-2022 (ELCEDE-UM) 10/01/2021 – 07/31/2024, (BF mPI), and the wastewater surveillance program (SEWER network grant, KRW and MCE co-PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Data-availability statement: The data supporting the findings of this study are available within the article and/or its supplementary materials.
Revision reorganizing the presentation for clarity and elaborates the discussion.
Data Availability
All data produced in the present work are contained in the manuscript.
